➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Moodys
Express Scripts
McKesson
Medtronic
Harvard Business School
Dow

Last Updated: May 30, 2020

DrugPatentWatch Database Preview

Litigation Details for NOVO NORDISK INC. v. TEVA PHARMACEUTICALS USA, INC. (D.N.J. 2014)


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

NOVO NORDISK INC. v. TEVA PHARMACEUTICALS USA, INC. (D.N.J. 2014)

Docket   Start Trial Date Filed 2014-07-03
Court District Court, D. New Jersey Date Terminated 2015-05-21
Cause 35:271 Patent Infringement Assigned To Michael Andre Shipp
Jury Demand None Referred To Douglas E. Arpert
Parties NOVO NORDISK FEMCARE AG; NOVO NORDISK INC.; TEVA PHARMACEUTICALS USA, INC.
Patents 5,860,946; 7,018,992
Attorneys CHARLES H. CHEVALIER; DAVID E. DELORENZI; MAYRA VELEZ TARANTINO; MICHAEL E. PATUNAS
Link to Docket External link to docket
Small Molecule Drugs cited in NOVO NORDISK INC. v. TEVA PHARMACEUTICALS USA, INC.
The small molecule drug covered by the patents cited in this case is   Start Trial .

Details for NOVO NORDISK INC. v. TEVA PHARMACEUTICALS USA, INC. (D.N.J. 2014)

Date Filed Document No. Description Snippet Link To Document
2014-07-03 1 United States Patent No. 7,018,992 (“the ‘992 patent”) and United States Patent No. 5,860,946 (“the ‘946… COUNT FOR INFRINGEMENT OF U.S. PATENT NO. 5,860,946 21. Plaintiffs re-allege… 1. This is an action for patent infringement under the patent laws of the United States, Title… THE PATENTS-IN-SUIT 8. On March 28, 2006, the United States Patent and Trademark… 1999, the United States Patent and Trademark Office issued the ‘946 patent, entitled “Instrument for External link to document
2014-07-23 7 expiration of U.S. Patent Nos. 7,018,992 (“the ‘992 patent”) and 5,860,946 (“the ‘946 patent”). The remaining…claims of U.S. Patent Nos. 7,018,992 (“the ‘992 patent”) and 5,860,946 (“the ‘946 patent”) are invalid… COUNT FOR INFRINGEMENT OF U.S. PATENT NO. 5,860,946 21. Teva incorporates each…purports to state an action for patent infringement under the patent laws of the United States, Title… THE PATENTS-IN-SUIT 8. Teva admits that according to the face of the ‘992 patent, the External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Mallinckrodt
Harvard Business School
Moodys
Medtronic
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.